That’s right. The last time we know that no MAA had been yet filed was November 17.
Nevertheless, the MIA commercial facility license at Sawston is a necessary achievement for ultimate DCVax-l commercial production.
What bears like to deemphasize and longs like to emphasize is that Sawston used DCVax-l production to prove the facility was capable of commercial production, and thus received the license.
Obviously Ex doesn’t want this to mean any overlap with the MA decision process, and obviously longs want it to mean even more than just overlap.
If you can wait until tomorrow morning, the company should update and answer many questions regarding their position.
I am part of the choir that believes, while MAA hasn’t been formally filed yet, there has almost certainly been a rolling submission of modules that will shorten the eventual MA decision.
Without going into how that process can be shortened or lengthened, it’s probably just best to wait for a (tomorrow?) PR before we speculate.
Anyway, this all is getting closer to wrapping NWBO with a neat little bow, potentially for some awaiting suitors. If I were short, I’d be worried that a potential deal of some sort could be much nearer at hand. Retail shorts could get severely burned, and it seems like they’ve been warned enough. Likewise, longs can never call something a sure thing, until it has happened. But retail shorts are truly playing with fire.
AI
Market Data 
Markets 
